Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) announced that on October 19, 2012 the company initiated oral dosing of healthy adult volunteers ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE